BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 24434653)

  • 1. RRM1 maintains centrosomal integrity via CHK1 and CDK1 signaling during replication stress.
    Kim SH; Park ER; Joo HY; Shen YN; Hong SH; Kim CH; Singh R; Lee KH; Shin HJ
    Cancer Lett; 2014 May; 346(2):249-56. PubMed ID: 24434653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA damage-induced accumulation of centrosomal Chk1 contributes to its checkpoint function.
    Löffler H; Bochtler T; Fritz B; Tews B; Ho AD; Lukas J; Bartek J; Krämer A
    Cell Cycle; 2007 Oct; 6(20):2541-8. PubMed ID: 17726372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Centrosomal Che-1 protein is involved in the regulation of mitosis and DNA damage response by mediating pericentrin (PCNT)-dependent Chk1 protein localization.
    Sorino C; Bruno T; Desantis A; Di Certo MG; Iezzi S; De Nicola F; Catena V; Floridi A; Chessa L; Passananti C; Cundari E; Fanciulli M
    J Biol Chem; 2013 Aug; 288(32):23348-57. PubMed ID: 23798705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Centrosome-associated Chk1 prevents premature activation of cyclin-B-Cdk1 kinase.
    Krämer A; Mailand N; Lukas C; Syljuåsen RG; Wilkinson CJ; Nigg EA; Bartek J; Lukas J
    Nat Cell Biol; 2004 Sep; 6(9):884-91. PubMed ID: 15311285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor suppressor protein C53 antagonizes checkpoint kinases to promote cyclin-dependent kinase 1 activation.
    Jiang H; Wu J; He C; Yang W; Li H
    Cell Res; 2009 Apr; 19(4):458-68. PubMed ID: 19223857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Depletion of Chk1 leads to premature activation of Cdc2-cyclin B and mitotic catastrophe.
    Niida H; Tsuge S; Katsuno Y; Konishi A; Takeda N; Nakanishi M
    J Biol Chem; 2005 Nov; 280(47):39246-52. PubMed ID: 16159883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclear Chk1 prevents premature mitotic entry.
    Matsuyama M; Goto H; Kasahara K; Kawakami Y; Nakanishi M; Kiyono T; Goshima N; Inagaki M
    J Cell Sci; 2011 Jul; 124(Pt 13):2113-9. PubMed ID: 21628425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA damage induces Chk1-dependent centrosome amplification.
    Bourke E; Dodson H; Merdes A; Cuffe L; Zachos G; Walker M; Gillespie D; Morrison CG
    EMBO Rep; 2007 Jun; 8(6):603-9. PubMed ID: 17468739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. UNC45A localizes to centrosomes and regulates cancer cell proliferation through ChK1 activation.
    Jilani Y; Lu S; Lei H; Karnitz LM; Chadli A
    Cancer Lett; 2015 Feb; 357(1):114-120. PubMed ID: 25444911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Depletion of BubR1 promotes premature centrosomal localization of cyclin B1 and accelerates mitotic entry.
    Park SY; Kim S; Cho H; Kwon SH; Chae S; Kang D; Seong YS; Cho H
    Cell Cycle; 2009 Jun; 8(11):1754-64. PubMed ID: 19411850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Essential function of Chk1 can be uncoupled from DNA damage checkpoint and replication control.
    Wilsker D; Petermann E; Helleday T; Bunz F
    Proc Natl Acad Sci U S A; 2008 Dec; 105(52):20752-7. PubMed ID: 19091954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chk1 is dispensable for G2 arrest in response to sustained DNA damage when the ATM/p53/p21 pathway is functional.
    Lossaint G; Besnard E; Fisher D; Piette J; Dulić V
    Oncogene; 2011 Oct; 30(41):4261-74. PubMed ID: 21532626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cep63 recruits Cdk1 to the centrosome: implications for regulation of mitotic entry, centrosome amplification, and genome maintenance.
    Löffler H; Fechter A; Matuszewska M; Saffrich R; Mistrik M; Marhold J; Hornung C; Westermann F; Bartek J; Krämer A
    Cancer Res; 2011 Mar; 71(6):2129-39. PubMed ID: 21406398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chk1- and claspin-dependent but ATR/ATM- and Rad17-independent DNA replication checkpoint response in HeLa cells.
    Rodríguez-Bravo V; Guaita-Esteruelas S; Florensa R; Bachs O; Agell N
    Cancer Res; 2006 Sep; 66(17):8672-9. PubMed ID: 16951182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chk1 instability is coupled to mitotic cell death of p53-deficient cells in response to virus-induced DNA damage signaling.
    Jurvansuu J; Fragkos M; Ingemarsdotter C; Beard P
    J Mol Biol; 2007 Sep; 372(2):397-406. PubMed ID: 17663993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ATR/Chk1 pathway is essential for resumption of DNA synthesis and cell survival in UV-irradiated XP variant cells.
    Despras E; Daboussi F; Hyrien O; Marheineke K; Kannouche PL
    Hum Mol Genet; 2010 May; 19(9):1690-701. PubMed ID: 20123862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA damage induces Chk1-dependent threonine-160 phosphorylation and activation of Cdk2.
    Bourke E; Brown JA; Takeda S; Hochegger H; Morrison CG
    Oncogene; 2010 Jan; 29(4):616-24. PubMed ID: 19838212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stalled replication induces p53 accumulation through distinct mechanisms from DNA damage checkpoint pathways.
    Ho CC; Siu WY; Lau A; Chan WM; Arooz T; Poon RY
    Cancer Res; 2006 Feb; 66(4):2233-41. PubMed ID: 16489026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two Distinct Cdc2 Pools Regulate Cell Cycle Progression and the DNA Damage Response in the Fission Yeast S.pombe.
    Caspari T; Hilditch V
    PLoS One; 2015; 10(7):e0130748. PubMed ID: 26131711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective Chk1 inhibitors differentially sensitize p53-deficient cancer cells to cancer therapeutics.
    Chen Z; Xiao Z; Gu WZ; Xue J; Bui MH; Kovar P; Li G; Wang G; Tao ZF; Tong Y; Lin NH; Sham HL; Wang JY; Sowin TJ; Rosenberg SH; Zhang H
    Int J Cancer; 2006 Dec; 119(12):2784-94. PubMed ID: 17019715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.